Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.

In recent years, the world has seen a surge in new and deadly infectious diseases, posing a major threat to global health.

The recent global monkeypox (mpox) outbreak, with a new and aggressive variant, has underscored the dire need for safe, broadly effective, and accessible vaccines. The LC16m8 vaccine, an attenuated ...

In recent years, the world has seen a surge in new and deadly infectious diseases, posing a major threat to global health. Outbreaks of COVID-19, H1N1 ...

Richard Lepke; Senior Director, Investor Relations; Vir Biotechnology Inc. Marianne De Backer; Chief Executive Officer, Director; Vir Biotechnology Inc. Mark Eisner; ...

VectorY Therapeutics, a biotech company developing disease-modifying vectorized antibody therapies for the treatment of neurodegenerative diseases, today announced the presentation of new preclinical ...

Turkey’s National Intelligence Organization (MIT) intercepted a cargo shipment at Istanbul Airport containing 1,300 explosive ...

Third, the severe clinical outcomes and EMA orphan disease designation support a value-based pricing model, similar to other ... the PRO-XTEN Dual Masked T-Cell Engager program.

Johnson & Johnson announces new data from Tremfya phase 3 QUASAR LTE study in adults with moderately-to-severely active ulcerative colitis: San Diego, California Tuesday, May 6, 2 ...

New Two-Step Flu Vaccine Strategy Shows Promise in Pig Model Aug. 9, 2024 — A new ... 2024 — Most influenza viruses enter human or animal cells through specific pathways on the cells' surface.